Psychiatry and Neurology, Neurology · Birmingham, AL
NPI
1275740060
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1717 6th Ave S
Birmingham, AL, 35233
Phone (800) 822-8816
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,852
174 services
Medicare patients, 2024
65
Average age 67
Drug cost, 2024
$3.5M
905 prescriptions
Company payments, 2025
$8,612
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Victor Sung was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 64 times for 53 patients. In total Victor Sung billed 174 services in 11 codes, and Medicare paid $7,852.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-29.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 64 | 53 | $10.17 | $651 |
| 99215 Office E&M - Established | Facility | 44 | 37 | $82.73 | $3,640 |
| 99214 Office E&M - Established | Facility | 16 | 14 | $57.71 | $923 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 15 | 11 | $12.04 | $181 |
By year: 2022 $9,587 for 120 services; 2023 $7,441 for 103 services; 2024 $7,852 for 174 services.
Medicare prescription drug claims, 2024
In 2024, the drug Victor Sung prescribed most often to Medicare patients was Austedo (Deutetrabenazine), with 158 prescriptions and refills. In total Victor Sung wrote 905 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Austedo Deutetrabenazine | 158 | 158 | 16 | $2.2M |
| Carbidopa-Levodopa Carbidopa/Levodopa | 95 | 181 | 32 | $4,836 |
| Clonazepam Generic | 68 | 84 | 14 | $263 |
| Austedo Xr Deutetrabenazine | 61 | 61 | Under 11 | $1.0M |
| Gabapentin Generic | 56 | 82 | Under 11 | $414 |
| Trazodone Hcl Generic | 36 | 60 | Under 11 | $254 |
| Modafinil Generic | 31 | 35 | Under 11 | $1,314 |
| Nuplazid Pimavanserin Tartrate | 30 | 32 | Under 11 | $160K |
| Aripiprazole Generic | 27 | 39 | Under 11 | $709 |
| Risperidone Generic | 25 | 36 | Under 11 | $237 |
| Sertraline Hcl Generic | 18 | 35 | Under 11 | $135 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 17 | 45 | Under 11 | $689 |
| Rasagiline Mesylate Generic | 17 | 47 | Under 11 | $4,940 |
| Quetiapine Fumarate Generic | 16 | 26 | Under 11 | $193 |
| Buspirone Hcl Generic | 15 | 15 | Under 11 | $362 |
Brand drugs: 268 claims; generic drugs: 637 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Victor Sung $8,612 ($8,612 in general payments such as food, travel and fees) from 10 companies. The largest payer was Neurocrine BioSciences, Inc. with $7,420.
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. NBIX | 3 | $7,420 |
| Sage Therapeutics, LLC SAGE | 1 | $531 |
| Teva Pharmaceuticals USA, Inc. TEVA | 2 | $178 |
| Medtronic, Inc. MDT | 2 | $142 |
| Supernus Pharmaceuticals, Inc. SUPN | 1 | $111 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $109 |
| Abbvie Inc. ABBV | 1 | $93.76 |
| Boston Scientific Corporation BSX | 1 | $27.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.